Whole-genome sequencing to control antimicrobial resistance.
Whole-genome sequencing to control antimicrobial resistance.
复制标题
DOI:
10.1016/j.tig.2014.07.003
复制
发表时间:
2014-09
期刊:
影响因子:
--
通讯作者:
Peacock SJ
中科院分区:
文献类型:
--
作者:
Köser CU;Ellington MJ;Peacock SJ
Owing to improvements in sequencing technologies, microbial whole-genome sequencing (WGS) has emerged as a central tool to control antibiotic resistance. WGS has been used to develop novel antibiotics and diagnostic tests. WGS has been key to surveillance and the study of the emergence of antibiotic resistance. Rapid WGS has the potential to be used as a tool for infection control in the clinic and, in some cases, as a primary diagnostic tool to detect resistance. Following recent improvements in sequencing technologies, whole-genome sequencing (WGS) is positioned to become an essential tool in the control of antibiotic resistance, a major threat in modern healthcare. WGS has already found numerous applications in this area, ranging from the development of novel antibiotics and diagnostic tests through to antibiotic stewardship of currently available drugs via surveillance and the elucidation of the factors that allow the emergence and persistence of resistance. Numerous proof-of-principle studies have also highlighted the value of WGS as a tool for day-to-day infection control and, for some pathogens, as a primary diagnostic tool to detect antibiotic resistance. However, appropriate data analysis platforms will need to be developed before routine WGS can be introduced on a large scale.